[1]
|
中华医学会呼吸病学分会慢性阻塞性肺疾病学组, 中国医师协会呼吸医师分会慢性阻塞性肺疾病工作委员会. 慢性阻塞性肺疾病诊治指南(2021年修订版) [J]. 中华结核和呼吸杂志, 2021, 44(3): 170-205.
|
[2]
|
Villgran, V.D., Lyons, C., Nasrullah, A., Clarisse Abalos, C., Bihler, E. and Alhajhusain, A. (2022) Acute Respiratory Failure. Critical Care Nursing Quarterly, 45, 233-247. https://doi.org/10.1097/CNQ.0000000000000408
|
[3]
|
Mizobuchi, K., Jujo, K., Minami, Y., Ishida, I., Nakao, M. and Hagiwara, N. (2019) The Baseline Nutritional Status Predicts Long-Term Mortality in Patients Undergoing Endovascular Therapy. Nutrients, 11, Article No. 1745.
https://doi.org/10.3390/nu11081745
|
[4]
|
Wang, Y., Xu, J., Meng, Y., Adcock, I.M. and Yao, X. (2018) Role of Inflammatory Cells in Airway Remodeling in COPD. The International Journal of Chronic Obstructive Pulmonary Disease, 13, 3341-3348.
https://doi.org/10.2147/COPD.S176122
|
[5]
|
Richmond, B.W., Du, R.H., Han, W., Benjamin, J.T., van der Meer, R., Gleaves, L., et al. (2018) Bacterial-Derived Neutrophilic Inflammation Drives Lung Remodeling in a Mouse Model of Chronic Obstructive Pulmonary Disease. American Journal of Respiratory Cell and Molecular Biology, 58, 736-744.
https://doi.org/10.1165/rcmb.2017-0329OC
|
[6]
|
Hirota, N. and Martin, J.G. (2013) Mechanisms of Airway Re-modeling. Chest, 144, 1026-1032.
https://doi.org/10.1378/chest.12-3073
|
[7]
|
Hogg, J.C. and Timens, W. (2009) The Pathology of Chronic Obstruc-tive Pulmonary Disease. Annual Review of Pathology, 4, 435-459. https://doi.org/10.1146/annurev.pathol.4.110807.092145
|
[8]
|
Sohal, S.S., Ward, C., Danial, W., Wood-Baker, R. and Walters, E.H. (2013) Recent Advances in Understanding Inflammation and Remodeling in the Airways in Chronic Obstructive Pulmonary Disease. Expert Review of Respiratory Medicine, 7, 275-288. https://doi.org/10.1586/ers.13.26
|
[9]
|
Mendy, A., Forno, E., Niyonsenga, T. and Gasana, J. (2018) Blood Bi-omarkers as Predictors of Long-Term Mortality in COPD. The Clinical Respiratory Journal, 12, 1891-1899. https://doi.org/10.1111/crj.12752
|
[10]
|
Bartoli, M.L., Costa, F., Malagrinò, L., et al. (2016) Sputum Inflammatory Cells in COPD Patients Classified According to GOLD 2011 Guidelines. European Respiratory Journal, 47, 978-980.
https://doi.org/10.1183/13993003.00784-2015
|
[11]
|
Wang, Y., Jia, M., Yan, X., et al. (2017) Increased Neutrophil Gelatinase-Associated Lipocalin (NGAL) Promotes Airway Remodelling in Chronic Obstructive Pulmonary Disease. Clinical Science (London), 131, 1147-1159.
https://doi.org/10.1042/CS20170096
|
[12]
|
Ostridge, K., Williams, N., Kim, V., et al. (2016) Relationship between Pulmonary Matrix Metalloproteinases and Quantitative CT Markers of Small Airways Disease and Emphysema in COPD. Thorax, 71, 126-132.
https://doi.org/10.1136/thoraxjnl-2015-207428
|
[13]
|
Polverino, E., Rosales-Mayor, E., Dale, G.E., Dembowsky, K. and Torres, A. (2017) The Role of Neutrophil Elastase Inhibitors in Lung Diseases. Chest, 152, 249-262. https://doi.org/10.1016/j.chest.2017.03.056
|
[14]
|
Guo, Y., Ma, L., Zhang, F., Sun, R. and Li, T. (2016) Neutrophil Elastase Ameliorates Matrix Metalloproteinase-9 to Promote Lipopolysaccharide-Induced Acute Lung Injury in Mice. Acta Cirúrgica Brasileira, 31, 382-388.
https://doi.org/10.1590/S0102-865020160060000004
|
[15]
|
Nauseef, W.M. (2018) Biosynthesis of Human Myeloperoxidase. Archives of Biochemistry and Biophysics, 642, 1-9.
https://doi.org/10.1016/j.abb.2018.02.001
|
[16]
|
Churg, A., Marshall, C.V., Sin, D.D., et al. (2012) Late Intervention with a Myeloperoxidase Inhibitor Stops Progression of Experimental Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine, 185, 34-43. https://doi.org/10.1164/rccm.201103-0468OC
|
[17]
|
Brusselle, G.G., Joos, G.F. and Bracke, K.R. (2011) New In-sights into the Immunology of Chronic Obstructive Pulmonary Disease. The Lancet, 378, 1015-1026. https://doi.org/10.1016/S0140-6736(11)60988-4
|
[18]
|
Aurora, A.B., Baluk, P., Zhang, D., et al. (2005) Immune Complex-Dependent Remodeling of the Airway Vasculature in Response to a Chronic Bacterial Infection. The Journal of Immunology, 175, 6319-6326.
https://doi.org/10.4049/jimmunol.175.10.6319
|
[19]
|
Kim, W.D., Chi, H.S., Choe, K.H., et al. (2013) A Possible Role for CD8+ and Non-CD8+ Cell Granzyme B in Early Small Airway Wall Remodelling in Centrilobular Emphysema. Respirology, 18, 688-696.
https://doi.org/10.1111/resp.12069
|
[20]
|
Majo, J., Ghezzo, H. and Cosio, M.G. (2001) Lymphocyte Population and Apoptosis in the Lungs of Smokers and Their Relation to Emphysema. European Respiratory Journal, 17, 946-953.
https://doi.org/10.1183/09031936.01.17509460
|
[21]
|
Bracke, K.R., Verhamme, F.M., Seys, L.J., et al. (2013) Role of CXCL13 in Cigarette Smoke-Induced Lymphoid Follicle Formation and Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine, 188, 343-355. https://doi.org/10.1164/rccm.201211-2055OC
|
[22]
|
Tan, H.L. and Rosenthal, M. (2013) IL-17 in Lung Disease: Friend or Foe? Thorax, 68, 788-790.
https://doi.org/10.1136/thoraxjnl-2013-203307
|
[23]
|
Arora, S., Dev, K., Agarwal, B., Das, P. and Syed, M.A. (2018) Macrophages: Their Role, Activation and Polarization in Pulmonary Diseases. Immunobiology, 223, 383-396. https://doi.org/10.1016/j.imbio.2017.11.001
|
[24]
|
Barnes, P.J. (2014) Cellular and Molecular Mechanisms of Chronic Obstructive Pulmonary Disease. Clinics in Chest Medicine, 35, 71-86. https://doi.org/10.1016/j.ccm.2013.10.004
|
[25]
|
Jundi, K. and Greene, C.M. (2015) Transcription of Interleukin-8: How Altered Regulation Can Affect Cystic Fibrosis Lung Disease. Biomolecules, 5, 1386-1398. https://doi.org/10.3390/biom5031386
|
[26]
|
Churg, A., Zhou, S., Wang, X., Wang, R. and Wright, J.L. (2009) The Role of Interleukin-1beta in Murine Cigarette Smoke-Induced Emphysema and Small Airway Remodeling. American Journal of Respiratory Cell and Molecular Biology, 40, 482-490. https://doi.org/10.1165/rcmb.2008-0038OC
|
[27]
|
Trojanek, J.B., Cobos-Correa, A., Diemer, S., et al. (2014) Air-way Mucus Obstruction Triggers Macrophage Activation and Matrix Metalloproteinase 12-Dependent Emphysema. American Journal of Respiratory Cell and Molecular Biology, 51, 709-720. https://doi.org/10.1165/rcmb.2013-0407OC
|
[28]
|
Yoshimura, T. (2018) The Chemokine MCP-1 (CCL2) in the Host Interaction with Cancer: A Foe or Ally? Cellular & Molecular Immunology, 15, 335-345. https://doi.org/10.1038/cmi.2017.135
|
[29]
|
Qian, M., Fang, X. and Wang, X. (2017) Autophagy and Inflammation. Clinical and Translational Medicine, 6, Article No. 24. https://doi.org/10.1186/s40169-017-0154-5
|
[30]
|
Erjefält, J.S. (2014) Mast Cells in Human Airways: The Culprit? European Respiratory Review, 23, 299-307.
https://doi.org/10.1183/09059180.00005014
|
[31]
|
Virk, H., Arthur, G. and Bradding, P. (2016) Mast Cells and Their Activation in Lung Disease. Translational Research, 174, 60-76. https://doi.org/10.1016/j.trsl.2016.01.005
|
[32]
|
Li, H., Yang, T., Ning, Q., et al. (2015) Cigarette Smoke Ex-tract-Treated Mast Cells Promote Alveolar Macrophage Infiltration and Polarization in Experimental Chronic Obstructive Pulmonary Disease. Inhalation Toxicology, 27, 822-831.
https://doi.org/10.3109/08958378.2015.1116644
|
[33]
|
Kosanovic, D., Dahal, B.K., Peters, D.M., et al. (2014) His-tological Characterization of Mast Cell Chymase in Patients with Pulmonary Hypertension and Chronic Obstructive Pul-monary Disease. Pulmonary Circulation, 4, 128-136.
https://doi.org/10.1086/675642
|
[34]
|
Mortaz, E., Folkerts, G. and Redegeld, F. (2011) Mast Cells and COPD. Pul-monary Pharmacology & Therapeutics, 24, 367-372. https://doi.org/10.1016/j.pupt.2011.03.007
|
[35]
|
Planas, M. and Burgos, R. (2000) Nutrición e insuficiencia respiratoria [Nutrition and Respiratory Insufficiency]. Nutrición Hospi-talaria, 15, 93-100.
|
[36]
|
Vincent, J.L. (2009) Relevance of Albumin in Modern Critical Care Medicine. Best Practice & Research Clinical Anaesthesiology, 23, 183-191. https://doi.org/10.1016/j.bpa.2008.11.004
|
[37]
|
Taverna, M., Ma-rie, A.L., Mira, J.P. and Guidet, B. (2013) Specific Antioxidant Properties of Human Serum Albumin. Annals of Inten-sive Care, 3, Article No. 4. https://doi.org/10.1186/2110-5820-3-4
|
[38]
|
Wiedermann, C.J. (2021) Hypoalbu-minemia as Surrogate and Culprit of Infections. International Journal of Molecular Sciences, 22, Article No. 4496. https://doi.org/10.3390/ijms22094496
|
[39]
|
Iglesias, J., Abernethy, V.E., Wang, Z., Lieberthal, W., Koh, J.S. and Levine, J.S. (1999) Albumin Is a Major Serum Survival Factor for Renal Tubular Cells and Macrophages through Scav-enging of ROS. American Journal of Physiology, 277, F711-F722. https://doi.org/10.1152/ajprenal.1999.277.5.F711
|
[40]
|
Phillips, A., Shaper, A.G. and Whincup, P.H. (1989) Asso-ciation between Serum Albumin and Mortality from Cardiovascular Disease, Cancer, and Other Causes. The Lancet, 2, 1434-1436.
https://doi.org/10.1016/S0140-6736(89)92042-4
|
[41]
|
Shen, S. and Xiao, Y. (2023) Association between C-Reactive Protein and Albumin Ratios and Risk of Mortality in Patients with Chronic Obstructive Pulmonary Disease. The International Journal of Chronic Obstructive Pulmonary Disease, 18, 2289-2303. https://doi.org/10.2147/COPD.S413912
|
[42]
|
Baldemir, R., Öztürk, A., Eraslan Doganay, G., Cirik, M.O. and Alagoz, A. (2022) Evaluation of Nutritional Status in Hospitalized Chronic Obstructive Pulmonary Disease Patients and Can C-Reactive Protein-to-Albumin Ratio Be Used in the Nutritional Risk Assessment in These Patients. Cureus, 14, e21833. https://doi.org/10.7759/cureus.21833
|
[43]
|
Wedzicha, J.A., Syndercombe-Court, D. and Tan, K.C. (1991) Increased Platelet Aggregate Formation in Patients with Chronic Airflow Obstruction and Hypoxaemia. Thorax, 46, 504-507. https://doi.org/10.1136/thx.46.7.504
|
[44]
|
Wedzicha, J.A., Cotter, F.E. and Empey, D.W. (1988) Platelet Size in Patients with Chronic Airflow Obstruction with and without Hypoxaemia. Thorax, 43, 61-64. https://doi.org/10.1136/thx.43.1.61
|
[45]
|
Liang, L.S., Mo, Y., Zhang, Z.Y., Liang, P.S. and Xu, P. (2022) Progress in Platelets and Chronic Obstructive Pulmonary Disease. Chinese Journal of Tuberculosis and Respiratory Diseases, 45, 1050-1054.
|
[46]
|
Hodgson, L. (2014) Predicting Death or Deterioration in Patients Admitted with Acute Exacerbation of COPD Using Physiological and Blood Parameters. Thorax, 69, A18. https://doi.org/10.1136/thoraxjnl-2014-206260.37
|
[47]
|
Benedik, B., Farkas, J., Kosnik, M., et al. (2011) Mini Nu-tritional Assessment, Body Composition, and Hospitalisations in Patients with Chronic Obstructive Pulmonary Disease. Respiratory Medicine, 105, S38-S43.
https://doi.org/10.1016/S0954-6111(11)70009-9
|
[48]
|
Almeida, A.I., Correia, M., Camilo, M. and Ravasco, P. (2012) Nutritional Risk Screening in Surgery: Valid, Feasible, Easy! Clinical Nutrition, 31, 206-211. https://doi.org/10.1016/j.clnu.2011.10.003
|
[49]
|
Cui, J., Wan, Q., Wu, X., Zeng Y, et al. (2015) Nutritional Risk Screening 2002 as a Predictor of Outcome during General Ward-Based Noninvasive Ventilation in Chronic Obstructive Pulmonary Disease with Respiratory Failure. Medical Science Monitor, 21, 2786-2793. https://doi.org/10.12659/MSM.894191
|